231 related articles for article (PubMed ID: 20840777)
21. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
Mouli S; Memon K; Baker T; Benson AB; Mulcahy MF; Gupta R; Ryu RK; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2013 Aug; 24(8):1227-34. PubMed ID: 23602420
[TBL] [Abstract][Full Text] [Related]
22. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
24. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
Imai K; Yamamoto M; Ariizumi S
Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
[TBL] [Abstract][Full Text] [Related]
25. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
Hong TS; DeLaney TF; Mamon HJ; Willett CG; Yeap BY; Niemierko A; Wolfgang JA; Lu HM; Adams J; Weyman EA; Arellano RS; Blaszkowsky LS; Allen JN; Tanabe KK; Ryan DP; Zhu AX
Pract Radiat Oncol; 2014; 4(5):316-322. PubMed ID: 25194100
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
27. Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy.
Stein DE; Heron DE; Rosato EL; Anné PR; Topham AK
Am J Clin Oncol; 2005 Feb; 28(1):21-3. PubMed ID: 15685030
[TBL] [Abstract][Full Text] [Related]
28. Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
Shaker TM; Chung C; Varma MK; Doherty MG; Wolf AM; Chung MH; Assifi MM
Am J Surg; 2018 Mar; 215(3):467-470. PubMed ID: 29395023
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of the survival of 123 patients with intrahepatic cholangiocarcinoma after surgical resection].
Bi C; Wang LM; An SL; Huang J; Feng RM; Wu F; Rong WQ; Wu JX
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):466-71. PubMed ID: 27346406
[TBL] [Abstract][Full Text] [Related]
30. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy.
Shimizu S; Okumura T; Oshiro Y; Fukumitsu N; Fukuda K; Ishige K; Hasegawa N; Numajiri H; Murofushi K; Ohnishi K; Mizumoto M; Nonaka T; Ishikawa H; Sakurai H
Radiat Oncol; 2019 Dec; 14(1):241. PubMed ID: 31881895
[TBL] [Abstract][Full Text] [Related]
32. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
[TBL] [Abstract][Full Text] [Related]
33. Image-guided radiation therapy for liver tumors: gastrointestinal histology matters.
Katsoulakis E; Riaz N; Cannon DM; Goodman K; Spratt DE; Lovelock M; Yamada Y
Am J Clin Oncol; 2014 Dec; 37(6):561-7. PubMed ID: 23466584
[TBL] [Abstract][Full Text] [Related]
34. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
35. Survival analysis of intrahepatic cholangiocarcinoma after resection.
Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
[TBL] [Abstract][Full Text] [Related]
36. Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma.
Zhang XX; Ma HB; Li TH; Huang B; Jia NY; Meng Y
Clin Transl Oncol; 2023 Mar; 25(3):731-738. PubMed ID: 36401766
[TBL] [Abstract][Full Text] [Related]
37. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
[TBL] [Abstract][Full Text] [Related]
38. External radiotherapy for decompression of cholangiocellular carcinoma with obstructive jaundice: report of a case.
Nakayama H; Tsuji K; Matsui R; Shiotani S; Atake S; Isaka N; Wada M; Tokuuye K; Ishikawa A; Akine Y
Radiat Med; 2001; 19(6):297-301. PubMed ID: 11837580
[TBL] [Abstract][Full Text] [Related]
39. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
[TBL] [Abstract][Full Text] [Related]
40. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
